Trump Administration Investigates 13 States Over Abortion Coverage Mandates

• AMA Board Chair Dr. Aizuss testified before Congress on March 20, 2026, highlighting financial challenges for physician practices impacting patient access to care nationwide. • He identified market consolidation, inadequate payments, prior authorization burdens, coverage instability, and workforce shortages as drivers of rising costs and longer waits. • Recommendations include prior authorization reform, restoring physician-owned hospitals, addressing physician shortages, and ensuring Medicaid sustainability amid changes.

• A new KFF survey from February-March 2026 shows 23 million ACA marketplace enrollees facing higher premiums after failed bipartisan subsidy extensions, forcing cuts to necessities. • Orlando resident Priscilla Brown, 48, rations Type 2 diabetes insulin to half or third doses or skips it entirely to manage costs despite insurance. • 75% worry about affording emergency care or hospitalization; 70% blame insurers 'a lot,' over half fault Republicans, Trump, and pharma companies.

• The California Medical Association strongly opposes a proposed statewide ballot initiative that would strip billions of dollars from vital community health centers. • The measure threatens funding for essential services provided by health clinics serving underserved populations across California. • CMA urges physicians and stakeholders to mobilize against the 'dangerous' proposal to protect community health infrastructure.

• CMS actuaries forecast U.S. health spending at $5.3 trillion in 2024, outpacing economic growth to hit 20% of GDP by 2033. • Projections highlight unsustainable trajectory for national health expenditures. • Policymakers face pressure to address cost drivers in insurance, drugs, and services.

• Democrats laying groundwork for major U.S. health care reforms amid political shifts in Washington. • NIH's Bhattacharya commits to full budget spending; top FDA official announces exit. • Moves signal potential policy battles over research funding and regulatory changes.

• Researchers using AI analyzed death certificates and estimated 155,000 additional unrecognized COVID-19 deaths outside hospitals in 2020-2021, raising the official toll of 840,000 by 16%. • The study compared symptomology of hospital deaths with those outside care, highlighting dramatic disparities in uncounted fatalities nationwide. • This undercounting underscores ongoing challenges in pandemic mortality tracking and public health surveillance across the U.S.

• Heartland Forward-commissioned research released March 19 reveals broad U.S. consensus on maternal health priorities and actionable steps forward. • Conducted in Bentonville, Ark., the poll finds Americans ready to address maternal care gaps nationwide. • Results point to unified public support for policy and community interventions to boost outcomes.

• Johnson & Johnson has received FDA approval for a new psoriasis treatment pill, expanding therapeutic options for patients with the chronic skin condition. • The United States smoking rate has quietly reached a historical low, reflecting decades of public health efforts and tobacco control policies. • These developments represent significant milestones in pharmaceutical innovation and public health outcomes across different therapeutic areas.

• A STAT national survey reveals NIH funding interruptions are causing layoffs, lab closures, and driving early-career scientists away from research careers due to federal budget and priority changes. • Harvard researcher Josiemer Mattei had her diabetes prevention trial in Puerto Rico terminated in May 2025 when the administration cut over $2.8 billion in grants across the university, forcing her to scramble to relocate the study to avoid losing patients and data. • The NIH remains committed to fully spending its 2026 budget but lags significantly behind prior years in grant awards and disbursements, with researchers reporting taking 95% pay cuts to avoid staff layoffs.

• State officials are warning that spring break 2026 travel season could facilitate the spread of measles across the United States as travelers move between regions with varying vaccination rates. • Health authorities are concerned about potential measles transmission during the high-travel period, with implications for public health preparedness and disease surveillance. • The warning underscores ongoing challenges in maintaining herd immunity and controlling vaccine-preventable diseases during major travel seasons.

• Trump 2.0 policies terminated or overhauled HHS advisory committees, including ACIP with all members replaced in January 2026 by RFK Jr., leading to weakened hepatitis B and COVID-19 vaccine recommendations. • NIH advisory councils have not met, with the director's committee disbanded for over a year; USPSTF has not met since March 2025. • Senator Murray criticized leadership for prohibiting NIH grant processes; new ACIP includes controversial figures like an Alzheimer's patient from the withdrawn aducanumab trial.